These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 20651168

  • 1. Comparison of active vitamin D compounds and a calcimimetic in mineral homeostasis.
    Nguyen-Yamamoto L, Bolivar I, Strugnell SA, Goltzman D.
    J Am Soc Nephrol; 2010 Oct; 21(10):1713-23. PubMed ID: 20651168
    [Abstract] [Full Text] [Related]

  • 2. 1α,24(S)(OH)2D2 normalizes bone morphology and serum parathyroid hormone without hypercalcemia in 25-hydroxyvitamin D-1-hydroxylase (CYP27B1)-deficient mice, an animal model of vitamin D deficiency with secondary hyperparathyroidism.
    St-Arnaud R, Arabian A, Yu VW, Akhouayri O, Knutson JC, Strugnell SA.
    J Endocrinol Invest; 2008 Aug; 31(8):711-7. PubMed ID: 18852532
    [Abstract] [Full Text] [Related]

  • 3. The efficacy of cinacalcet combined with conventional therapy on bone and mineral metabolism in dialysis patients with secondary hyperparathyroidism: a meta-analysis.
    Li D, Shao L, Zhou H, Jiang W, Zhang W, Xu Y.
    Endocrine; 2013 Feb; 43(1):68-77. PubMed ID: 22669774
    [Abstract] [Full Text] [Related]

  • 4. Correction of the abnormal mineral ion homeostasis with a high-calcium, high-phosphorus, high-lactose diet rescues the PDDR phenotype of mice deficient for the 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1).
    Dardenne O, Prud'homme J, Hacking SA, Glorieux FH, St-Arnaud R.
    Bone; 2003 Apr; 32(4):332-40. PubMed ID: 12689675
    [Abstract] [Full Text] [Related]

  • 5. Exogenous PTH-related protein and PTH improve mineral and skeletal status in 25-hydroxyvitamin D-1alpha-hydroxylase and PTH double knockout mice.
    Xue Y, Zhang Z, Karaplis AC, Hendy GN, Goltzman D, Miao D.
    J Bone Miner Res; 2005 Oct; 20(10):1766-77. PubMed ID: 16160734
    [Abstract] [Full Text] [Related]

  • 6. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
    Torres PU.
    J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
    [Abstract] [Full Text] [Related]

  • 7. Impact of cinacalcet hydrochloride on bone histology in patients with secondary hyperparathyroidism.
    Yajima A, Akizawa T, Tsukamoto Y, Kurihara S, Ito A, K Study Group.
    Ther Apher Dial; 2008 Oct; 12 Suppl 1():S38-43. PubMed ID: 19032526
    [Abstract] [Full Text] [Related]

  • 8. The calcimimetic AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalities in uremic rats.
    Henley C, Davis J, Miller G, Shatzen E, Cattley R, Li X, Martin D, Yao W, Lane N, Shalhoub V.
    Eur J Pharmacol; 2009 Aug 15; 616(1-3):306-13. PubMed ID: 19470383
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Exogenous PTH and endogenous 1,25-dihydroxyvitamin D are complementary in inducing an anabolic effect on bone.
    Samadfam R, Xia Q, Miao D, Hendy GN, Goltzman D.
    J Bone Miner Res; 2008 Aug 15; 23(8):1257-66. PubMed ID: 18348699
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Generation of 1,25-dihydroxyvitamin D3 in Cyp27b1 knockout mice by treatment with 25-hydroxyvitamin D3 rescued their rachitic phenotypes.
    Nishikawa M, Yasuda K, Takamatsu M, Abe K, Nakagawa K, Tsugawa N, Hirota Y, Tanaka K, Yamashita S, Ikushiro S, Suda T, Okano T, Sakaki T.
    J Steroid Biochem Mol Biol; 2019 Jan 15; 185():71-79. PubMed ID: 30031146
    [Abstract] [Full Text] [Related]

  • 14. Exogenous 1,25-dihydroxyvitamin D3 exerts a skeletal anabolic effect and improves mineral ion homeostasis in mice that are homozygous for both the 1alpha-hydroxylase and parathyroid hormone null alleles.
    Xue Y, Karaplis AC, Hendy GN, Goltzman D, Miao D.
    Endocrinology; 2006 Oct 15; 147(10):4801-10. PubMed ID: 16857747
    [Abstract] [Full Text] [Related]

  • 15. Implementation of 'K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease' after the introduction of cinacalcet in a population of patients on chronic haemodialysis.
    Arenas MD, Alvarez-Ude F, Gil MT, Moledous A, Malek T, Nuñez C, Devesa R, Carretón MA, Soriano A.
    Nephrol Dial Transplant; 2007 Jun 15; 22(6):1639-44. PubMed ID: 17277339
    [Abstract] [Full Text] [Related]

  • 16. The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells.
    Brown AJ, Ritter CS, Knutson JC, Strugnell SA.
    Nephrol Dial Transplant; 2006 Mar 15; 21(3):644-50. PubMed ID: 16221703
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 15; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.